CD274 and nonpapillary renal cell carcinoma: Furthermore, stronger expression of PD-L1 has been detected in the metastatic samples of CCRCC in comparison to primary samples and its augmented expression on tumor cells and infiltrating lymphocytes of patients suffering from metastatic renal cell carcinoma has been demonstrated [67, 150, 152–156].